adjunctive therapy

Adjunctive Therapy

Medspeak Any therapeutic manoeuvre ancillary to the care needed short term to stabilise a patient, but which reduces the morbidity and mortality long term.
Example Immediate therapy for an acute myocardial infarction includes O2, tPA, stenting, angioplasty, etc. Adjunctive therapy includes aspirin, beta-blockers, ACE inhibitors, heparin, nitrates, calcium channel blockers, antiarrhythmic agents, magnesium, morphine, warfarin, & hypolipidemic agents—e.g., simvastin.
Psychiatry Mental health care, including occupational, recreational, or creative therapy which is ancillary to the principal intervention, which may also have a role as primary therapy.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

adjunctive therapy

Medtalk A therapeutic maneuver(s) with an ancillary role in treating a disease by ↓ M&M, but not part of the immediate therapy required to stabilize the Pt. Cf Adjuvant therapy.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

ad·junc·tive ther·a·py

(ad-jungk'tiv thār'ă-pē)
Any accessory treatment used in combination to enhance primary treatment.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
The phase two study is a multicentre, randomised, double-blind, placebo-controlled three-arm study to evaluate the safety and tolerability of multiple oral doses of REL-1017 25mg and 50mg as adjunctive therapy in the treatment of patients diagnosed with major depressive disorder.
Food and Drug Administration approved multiple applications for first generics of Lyrica for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury, the agency announced today.
In conjunction, the paediatric exclusivity determination is based on data from the company's LYRICA Paediatric Epilepsy Programme, which were submitted in response to the US FDA's Written Request to evaluate the use of LYRICA as adjunctive therapy for partial onset seizures in paediatric epilepsy patients.
"Removal without adjunctive therapy is a guaranteed failure--about 100% of the time in my experience.
The approval was based on efficacy and safety data from a pivotal Phase III study, EXIST-3 (Examining everolimus In a Study of TSC), which found that when used as an adjunctive therapy, Afinitor DISPERZ significantly reduced the frequency of treatment-resistant seizures associated with TSC compared to placebo.
A highly selective, noncompetitive AMPA receptor antagonist that reduces neuronal hyperexcitation associated with seizures by targeting glutamate activity at AMPA receptors, it is approved in countries around the world as an adjunctive therapy for the treatment of POS with or without secondarily generalized seizures, and primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy 12 years of age and older.
LATUDA is indicated for the treatment of major depressive episodes associated with bipolar I disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate in adults.
announced that the FDA has approved Fycompa (perampanel) CIII for adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures, one of the most common and severe forms of generalized seizures with a high incidence of morbidity and mortality.
This study is the first trial investigating the efficacy and safety of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome receiving standard treatment.
According to doctors, it is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb).
Lacosamide has already been approved as an adjunctive therapy for partial onset seizures in adults with epilepsy in 36 countries.